A detailed history of Lri Investments, LLC transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Lri Investments, LLC holds 55 shares of CDTX stock, worth $5,521. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Holding current value
$5,521
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$47.87 - $96.98 $2,632 - $5,333
55 New
55 $5.27 Million

Others Institutions Holding CDTX

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $7.03B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.